Application of ’omics technologies to biomarker discovery in inflammatory lung diseases

Inflammatory lung diseases are highly complex in respect of pathogenesis and relationships between inflammation, clinical disease and response to treatment. Sophisticated large-scale analytical methods to quantify gene expression (transcriptomics), proteins (proteomics), lipids (lipidomics) and metabolites (metabolomics) in the lungs, blood and urine are now available to identify biomarkers that define disease in terms of combined clinical, physiological and patho-biological abnormalities. The aspiration is that these approaches will improve diagnosis, i.e. define pathological phenotypes, and facilitate the monitoring of disease and therapy, and also, unravel underlying molecular pathways. Biomarker studies can either select predefined biomarker(s) measured by specific methods or apply an “unbiased” approach involving detection platforms that are indiscriminate in focus. This article reviews the technologies presently available to study biomarkers of lung disease within the ’omics field. The contributions of the individual ’omics analytical platforms to the field of respiratory diseases are summarised, with the goal of providing background on their respective abilities to contribute to systems medicine-based studies of lung disease. Summary of the application of ’omics-based analytical platforms for biomarker discovery in inflammatory lung diseases http://ow.ly/mjGGc

[1]  Margaret Cseke,et al.  Genomics, Proteomics, and Metabolomics , 2011, Advances in Environmental Engineering and Green Technologies.

[2]  G. Omenn,et al.  Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .

[3]  David Haussler,et al.  The UCSC genome browser and associated tools , 2012, Briefings Bioinform..

[4]  T. Franquet,et al.  [Idiopathic interstitial pneumonias]. , 2012, Radiologia.

[5]  S. Dahlén,et al.  Application of metabolomics approaches to the study of respiratory diseases. , 2012, Bioanalysis.

[6]  Rudi Balling,et al.  Revolutionizing medicine in the 21st century through systems approaches. , 2012, Biotechnology journal.

[7]  Susumu Goto,et al.  Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics , 2012, BMC Medical Genomics.

[8]  S. Gupta,et al.  Lung damage and airway remodelling in severe asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  Jaeyun Sung,et al.  Molecular signatures from omics data: From chaos to consensus , 2012, Biotechnology journal.

[10]  Fabian J Theis,et al.  The dynamic range of the human metabolome revealed by challenges , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[12]  J. Haeggström,et al.  Allergic Asthmatics Show Divergent Lipid Mediator Profiles from Healthy Controls Both at Baseline and following Birch Pollen Provocation , 2012, PloS one.

[13]  Jean-Eudes Dazard,et al.  Human Biomarker Discovery and Predictive Models for Disease Progression for Idiopathic Pneumonia Syndrome Following Allogeneic Stem Cell Transplantation* , 2012, Molecular & Cellular Proteomics.

[14]  Qing Zeng-Treitler,et al.  Predicting sample size required for classification performance , 2012, BMC Medical Informatics and Decision Making.

[15]  S. Ohlmeier,et al.  Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD. , 2012, Journal of proteome research.

[16]  P. Montuschi,et al.  Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects , 2012, European Respiratory Journal.

[17]  M. Jordana,et al.  Shifting of Immune Responsiveness to House Dust Mite by Influenza A Infection: Genomic Insights , 2012, The Journal of Immunology.

[18]  S. Stanley Young,et al.  Power and Sample Size Calculation for Microarray Studies , 2012, Journal of biopharmaceutical statistics.

[19]  T. Mcclanahan,et al.  Biomarkers of Disease and Treatment in Murine and Cynomolgus Models of Chronic Asthma , 2012, Biomarker insights.

[20]  Chris T. A. Evelo,et al.  WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..

[21]  Gautier Koscielny,et al.  Ensembl 2012 , 2011, Nucleic Acids Res..

[22]  Kian Fan Chung,et al.  Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. , 2012, The Journal of allergy and clinical immunology.

[23]  Ravi Iyengar,et al.  Systems biology of kidney diseases. , 2012, Kidney international.

[24]  C. Guillou,et al.  Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. , 2012, Biomedical chromatography : BMC.

[25]  J. Riley,et al.  Metabolic profiling detects biomarkers of protein degradation in COPD patients , 2011, European Respiratory Journal.

[26]  J. Lötvall,et al.  Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities. , 2011, Journal of proteomics.

[27]  Hisashi Noma,et al.  Estimating Effect Sizes of Differentially Expressed Genes for Power and Sample‐Size Assessments in Microarray Experiments , 2011, Biometrics.

[28]  D. Goodlett,et al.  Induced sputum proteome in healthy subjects and asthmatic patients. , 2011, The Journal of allergy and clinical immunology.

[29]  H. Kitano,et al.  Software for systems biology: from tools to integrated platforms , 2011, Nature Reviews Genetics.

[30]  K. Weinberger,et al.  Targeted metabolomics for bioprocessing , 2011, BMC proceedings.

[31]  Debora Paris,et al.  NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis , 2011, Thorax.

[32]  Mattias Rantalainen,et al.  Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model , 2011, Proteome Science.

[33]  Michel Dumontier,et al.  Controlled vocabularies and semantics in systems biology , 2011, Molecular systems biology.

[34]  M. Burdick,et al.  Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. , 2011, Biochemical and biophysical research communications.

[35]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[36]  H. Kinney,et al.  Brainstem Deficiency of the 14-3-3 Regulator of Serotonin Synthesis: A Proteomics Analysis in the Sudden Infant Death Syndrome* , 2011, Molecular & Cellular Proteomics.

[37]  J. Haeggström,et al.  Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. , 2011, Chemical reviews.

[38]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[39]  A. Cebrián,et al.  Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics , 2011, Clinical and Translational Oncology.

[40]  Josep Roca,et al.  A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease , 2011, PLoS Comput. Biol..

[41]  Peter Donnelly,et al.  Human metabolic profiles are stably controlled by genetic and environmental variation , 2011, Molecular Systems Biology.

[42]  Anders Eklund,et al.  Asthmatics Exhibit Altered Oxylipin Profiles Compared to Healthy Individuals after Subway Air Exposure , 2011, PloS one.

[43]  A. Clark,et al.  Biologic Phenotyping of the Human Small Airway Epithelial Response to Cigarette Smoking , 2011, PloS one.

[44]  Ashley Woodcock,et al.  Non-invasive phenotyping using exhaled volatile organic compounds in asthma , 2011, Thorax.

[45]  S. Dahlén,et al.  Lipid mediator profiling in pulmonary disease. , 2011, Current pharmaceutical biotechnology.

[46]  J. Lausmaa,et al.  TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls , 2011, European Respiratory Journal.

[47]  Stefan R Bornstein,et al.  Bottom-up shotgun lipidomics by higher energy collisional dissociation on LTQ Orbitrap mass spectrometers. , 2011, Analytical chemistry.

[48]  F H Krouwels,et al.  Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD , 2011, European Respiratory Journal.

[49]  Sophia Ananiadou,et al.  Discovering and visualizing indirect associations between biomedical concepts , 2011, Bioinform..

[50]  Avrum Spira,et al.  Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq , 2011, Cancer Prevention Research.

[51]  B. Oliver,et al.  Microarrays, deep sequencing and the true measure of the transcriptome , 2011, BMC Biology.

[52]  M. Clench,et al.  MALDI-MS imaging of lipids in ex vivo human skin , 2011, Analytical and bioanalytical chemistry.

[53]  M. Wilm Principles of Electrospray Ionization , 2011, Molecular & Cellular Proteomics.

[54]  S. Letovsky,et al.  Protocol Dependence of Sequencing-Based Gene Expression Measurements , 2011, PloS one.

[55]  F Kauffmann,et al.  MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine , 2011, Allergy.

[56]  Ralf J. M. Weber,et al.  Characterization of isotopic abundance measurements in high resolution FT-ICR and Orbitrap mass spectra for improved confidence of metabolite identification. , 2011, Analytical chemistry.

[57]  S. Dahlén,et al.  Lipid mediators in severe asthma , 2011 .

[58]  K. Chung,et al.  Difficult-to-Treat Severe Asthma , 2011 .

[59]  Erik J. Saude,et al.  Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. , 2011, The Journal of allergy and clinical immunology.

[60]  B. Domon,et al.  Selected reaction monitoring applied to proteomics. , 2011, Journal of mass spectrometry : JMS.

[61]  Jason Liao,et al.  Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. , 2011, Journal of proteome research.

[62]  Barmak Modrek,et al.  Gene Expression Patterns of Th2 Inflammation and Intercellular Communication in Asthmatic Airways , 2011, The Journal of Immunology.

[63]  S. Dahlén,et al.  Effects of celecoxib on major prostaglandins in asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[64]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[65]  Jordi Villà-Freixa,et al.  Knowledge management for systems biology a general and visually driven framework applied to translational medicine , 2011, BMC Systems Biology.

[66]  Zsofia Lazar,et al.  Electronic Nose Breathprints Are Independent of Acute Changes in Airway Caliber in Asthma , 2010, Sensors.

[67]  K. Carlsen,et al.  Eoxins: a new inflammatory pathway in childhood asthma. , 2010, The Journal of allergy and clinical immunology.

[68]  Michael Eiden,et al.  Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks. , 2010, Analytical chemistry.

[69]  Edwin K Silverman,et al.  Chronic obstructive pulmonary disease phenotypes: the future of COPD. , 2010, American journal of respiratory and critical care medicine.

[70]  S. Wijmenga,et al.  Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples* , 2010, Molecular & Cellular Proteomics.

[71]  N. Kaminski,et al.  Have advanced research technologies made real impact on respiratory medicine? , 2010, Respirology.

[72]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[73]  E. Perakslis,et al.  Effective knowledge management in translational medicine , 2010, Journal of Translational Medicine.

[74]  Michaela Scigelova,et al.  Coupling liquid chromatography to Orbitrap mass spectrometry. , 2010, Journal of chromatography. A.

[75]  Charles Auffray,et al.  An integrative systems biology approach to understanding pulmonary diseases. , 2010, Chest.

[76]  P. Howarth,et al.  Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[77]  E. Perakslis,et al.  How Informatics Can Potentiate Precompetitive Open‐Source Collaboration to Jump‐Start Drug Discovery and Development , 2010, Clinical pharmacology and therapy.

[78]  Giorgio Pennazza,et al.  Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. , 2010, Chest.

[79]  J W Dallinga,et al.  A profile of volatile organic compounds in breath discriminates COPD patients from controls. , 2009, Respiratory medicine.

[80]  Joseph K. Pickrell,et al.  Understanding mechanisms underlying human gene expression variation with RNA sequencing , 2010, Nature.

[81]  Pingbo Zhang,et al.  Multiplex assays for biomarker research and clinical application: Translational science coming of age , 2010, Proteomics. Clinical applications.

[82]  Matthew A. Hibbs,et al.  Visualization of omics data for systems biology , 2010, Nature Methods.

[83]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[84]  A. Gabrielsen,et al.  The use of network analyses for elucidating mechanisms in cardiovascular disease. , 2010, Molecular bioSystems.

[85]  Christer S. Ejsing,et al.  Orm family proteins mediate sphingolipid homeostasis , 2010, Nature.

[86]  Q. Jöbsis,et al.  Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[87]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[88]  E. Wouters,et al.  Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[89]  D. Porteous,et al.  SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. , 2010, Clinical biochemistry.

[90]  D. Voelker,et al.  Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus–induced inflammation and infection , 2009, Proceedings of the National Academy of Sciences.

[91]  R. Peverall,et al.  A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis , 2009, Journal of breath research.

[92]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[93]  J. Chun,et al.  Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma , 2009, Respiratory research.

[94]  Thorsten Meinl,et al.  KNIME - the Konstanz information miner: version 2.0 and beyond , 2009, SKDD.

[95]  H. Collard,et al.  Idiopathic interstitial pneumonias. , 2009, Journal of thoracic imaging.

[96]  A. Yamasaki,et al.  Lipid metabolites as regulators of airway smooth muscle function. , 2009, Pulmonary pharmacology & therapeutics.

[97]  N. Higashi,et al.  Concentration of 14,15‐leukotriene C4 (eoxin C4) in bronchoalveolar lavage fluid , 2009, Clinical and Experimental Allergy.

[98]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[99]  Sarala M. Wimalaratne,et al.  The Systems Biology Graphical Notation , 2009, Nature Biotechnology.

[100]  D. Noble,et al.  Systems biology and the virtual physiological human , 2009, Molecular systems biology.

[101]  John R Yates,et al.  Proteomics by mass spectrometry: approaches, advances, and applications. , 2009, Annual review of biomedical engineering.

[102]  S. Milstien,et al.  Export and functions of sphingosine-1-phosphate. , 2009, Biochimica et biophysica acta.

[103]  I. Horváth,et al.  Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.

[104]  Alvis Brazma,et al.  Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges , 2009, TheScientificWorldJournal.

[105]  Susumu Goto,et al.  Systems biology approaches and pathway tools for investigating cardiovascular disease. , 2009, Molecular bioSystems.

[106]  C. Liu,et al.  15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[107]  Christopher J. Nelson,et al.  Advantages of next-generation sequencing versus the microarray in epigenetic research. , 2009, Briefings in functional genomics & proteomics.

[108]  J. Brody,et al.  Comparison of Proteomic and Transcriptomic Profiles in the Bronchial Airway Epithelium of Current and Never Smokers , 2009, PloS one.

[109]  L. Wehenkel,et al.  Biomarker discovery in asthma‐related inflammation and remodeling , 2009, Proteomics.

[110]  Inyoul Y. Lee,et al.  A systems approach to prion disease , 2009, Molecular systems biology.

[111]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[112]  Magnus Palmblad,et al.  Mass spectrometry in clinical proteomics – from the present to the future , 2008, Proteomics. Clinical applications.

[113]  Lincoln Stein,et al.  Reactome knowledgebase of human biological pathways and processes , 2008, Nucleic Acids Res..

[114]  P. Elliott,et al.  Size matters: just how big is BIG? , 2008, International journal of epidemiology.

[115]  W. Kolch,et al.  Genomics, Proteomics and Metabolomics , 2009 .

[116]  Barbara M. Bakker,et al.  Systems biology towards life in silico: mathematics of the control of living cells , 2009, Journal of mathematical biology.

[117]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[118]  N. Krug,et al.  Therapeutic use of surfactant components in allergic asthma , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[119]  G. Corso,et al.  Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy , 2008, European Respiratory Journal.

[120]  E. Knol,et al.  Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes , 2008, European Respiratory Journal.

[121]  A. Valencia,et al.  Linking genes to literature: text mining, information extraction, and retrieval applications for biology , 2008, Genome Biology.

[122]  J. Austin,et al.  Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[123]  N. Kikuchi,et al.  CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks , 2008, Proceedings of the IEEE.

[124]  J. Stark,et al.  Systems biology of persistent infection: tuberculosis as a case study , 2008, Nature Reviews Microbiology.

[125]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[126]  A. Wheeler,et al.  A practical interface for microfluidics and nanoelectrospray mass spectrometry , 2008, Electrophoresis.

[127]  M. Santonico,et al.  Olfactory systems for medical applications , 2008 .

[128]  S. Spiegel,et al.  The role of sphingosine-1-phosphate and its receptors in asthma. , 2008, Drug news & perspectives.

[129]  D. Smallwood,et al.  Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[130]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[131]  M. Björkholm,et al.  Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells , 2008, Proceedings of the National Academy of Sciences.

[132]  Peng Liu,et al.  Gene expression: Quick calculation for sample size while controlling false discovery rate with application to microarray analysis , 2007, Bioinform..

[133]  Ncbi National Center for Biotechnology Information , 2008 .

[134]  Muin J. Khoury,et al.  Quantifying realistic sample size requirements for human genome epidemiology , 2008 .

[135]  D. Chan,et al.  SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. , 2008, Clinical chemistry.

[136]  Michael C. Thomas,et al.  Ozone-induced dissociation: elucidation of double bond position within mass-selected lipid ions. , 2008, Analytical chemistry.

[137]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[138]  Yee Hwa Yang,et al.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids , 2007, Proceedings of the National Academy of Sciences.

[139]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[140]  Gonçalo R. Abecasis,et al.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.

[141]  Károly Héberger,et al.  Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.

[142]  J. Albrethsen Reproducibility in protein profiling by MALDI-TOF mass spectrometry. , 2007, Clinical chemistry.

[143]  Stephen T Holgate,et al.  Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[144]  A. Dupuy,et al.  Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.

[145]  Eoin Fahy,et al.  The lipid maps initiative in lipidomics. , 2007, Methods in enzymology.

[146]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[147]  Ronald G. Crystal,et al.  Modification of gene expression of the small airway epithelium in response to cigarette smoking , 2006, Journal of Molecular Medicine.

[148]  T. Honda,et al.  Characteristics of COPD phenotypes classified according to the findings of HRCT. , 2006, Respiratory medicine.

[149]  Zulfiqur Ali,et al.  Data analysis for electronic nose systems , 2006 .

[150]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[151]  B. Nicholas,et al.  Shotgun proteomic analysis of human‐induced sputum , 2006, Proteomics.

[152]  B. Palsson,et al.  The model organism as a system: integrating 'omics' data sets , 2006, Nature Reviews Molecular Cell Biology.

[153]  M. Gorenstein,et al.  Absolute Quantification of Proteins by LCMSE , 2006, Molecular & Cellular Proteomics.

[154]  R. Bowler,et al.  Surface Enhanced Laser Desorption/Ionization (SELDI) Time-of-Flight Mass Spectrometry to Identify Patients with Chronic Obstructive Pulmonary Disease , 2006, COPD.

[155]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[156]  R. Gawlik,et al.  FROM ASTHMATIC PATIENTS , 2006 .

[157]  A. Heguy,et al.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking , 2006, Journal of Molecular Medicine.

[158]  David B. Allison,et al.  The PowerAtlas: a power and sample size atlas for microarray experimental design and research , 2006, BMC Bioinformatics.

[159]  A. Higashi,et al.  Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis , 2005, European Respiratory Journal.

[160]  K. Chung,et al.  Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma , 2005, Science's STKE.

[161]  Charles Auffray,et al.  'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments. , 2005, Drug discovery today.

[162]  P. J. Barnes,et al.  Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.

[163]  P. Sundgren,et al.  Magnetic resonance spectroscopy. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[164]  M. Lenter,et al.  Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface‐enhanced laser desorption/ionization‐mass spectrometry profiling with mass spectrometric protein identification , 2005, Proteomics.

[165]  David Harel,et al.  On mappings between electronic noses , 2005 .

[166]  Xianlin Han,et al.  Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.

[167]  R. Balkrishnan,et al.  Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[168]  C. Coopersmith,et al.  Epithelial cells , 1991 .

[169]  Shuying Liu,et al.  High resolution mass spectrometric alveolar proteomics: Identification of surfactant protein SP‐A and SP‐D modifications in proteinosis and cystic fibrosis patients , 2004, Proteomics.

[170]  S. Dahlén,et al.  Measuring quality of life in patients with sleep apnoea: whose life is it anyway? , 2004, Thorax.

[171]  A. Szczeklik,et al.  Plasma 9α,11β-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma , 2004, Thorax.

[172]  P. Montuschi,et al.  Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients , 2004, Thorax.

[173]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[174]  Charles Auffray,et al.  From functional genomics to systems biology: concepts and practices. , 2003, Comptes rendus biologies.

[175]  David Moher,et al.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. , 2003, Croatian medical journal.

[176]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[177]  S. Holgate,et al.  Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma , 2003, European Respiratory Journal.

[178]  A. Szczeklik,et al.  A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. , 2003, The Journal of allergy and clinical immunology.

[179]  Dennis Bray,et al.  Molecular Prodigality , 2003, Science.

[180]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[181]  P. Gibson,et al.  Biomarkers of lipid peroxidation, airway inflammation and asthma , 2003, European Respiratory Journal.

[182]  S. Wenzel,et al.  Expression and activation of 15‐lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[183]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[184]  Eugene Y. Kim,et al.  Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.

[185]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[186]  M. Griese,et al.  Protein pattern of exhaled breath condensate and saliva , 2002, Proteomics.

[187]  J. Bousquet,et al.  Lipoxins are potential endogenous antiinflammatory mediators in asthma. , 2002, American journal of respiratory and critical care medicine.

[188]  D. Romberger,et al.  Lysophosphatidic acid in airway function and disease , 2002 .

[189]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[190]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[191]  J. Cracowski,et al.  Increased lipid peroxidation in patients with pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.

[192]  Oliver Fiehn,et al.  Combining Genomics, Metabolome Analysis, and Biochemical Modelling to Understand Metabolic Networks , 2001, Comparative and functional genomics.

[193]  S. Spiegel,et al.  Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[194]  A. Matsukawa,et al.  Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection , 2001, Critical care medicine.

[195]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[196]  Ian M. Donaldson,et al.  BIND: the Biomolecular Interaction Network Database , 2001, Nucleic Acids Res..

[197]  S T Holgate,et al.  Altered airway surfactant phospholipid composition and reduced lung function in asthma. , 2000, Journal of applied physiology.

[198]  Paul A. Haynes,et al.  Proteome Profiling—Pitfalls and Progress , 2000, Yeast.

[199]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[200]  N. Krug,et al.  Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[201]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[202]  J. Morrow,et al.  Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. , 1999, American journal of respiratory and critical care medicine.

[203]  P. Montuschi,et al.  Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro. , 1999, European journal of pharmacology.

[204]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[205]  L. Touqui,et al.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. , 1998, The Journal of clinical investigation.

[206]  F Baganz,et al.  Systematic functional analysis of the yeast genome. , 1998, Trends in biotechnology.

[207]  M. Stulbarg,et al.  OBSTRUCTIVE PULMONARY DISEASE: The Clinician's Perspective , 1998 .

[208]  M. Phillips Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.

[209]  L. Gallo Cardiovascular Disease , 1995, GWUMC Department of Biochemistry Annual Spring Symposia.

[210]  S. Dahlén,et al.  Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. , 1992, The American review of respiratory disease.

[211]  J. Morrow,et al.  Formation of unique biologically active prostaglandins in vivo by a non-cyclooxygenase free radical catalyzed mechanism. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[212]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[213]  M. Hamberg,et al.  15(S)-hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium. , 1990, Archives of biochemistry and biophysics.

[214]  S. Marney,et al.  Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. , 1990, The American review of respiratory disease.

[215]  D. Lipman,et al.  National Center for Biotechnology Information , 2019, Springer Reference Medizin.

[216]  R. Dixon,et al.  Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis , 1990, Nature.

[217]  M. Mann,et al.  Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.

[218]  S. Dahlén,et al.  Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[219]  C. Serhan,et al.  Lipoxins: a new series of eicosanoids (biosynthesis, stereochemistry, and biological activities). , 1988, Advances in experimental medicine and biology.

[220]  Robert A. Lewis,et al.  Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.

[221]  P. Paré,et al.  Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro , 1981, Nature.

[222]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.

[223]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[224]  Williams Mh,et al.  OBSTRUCTIVE PULMONARY DISEASE , 1964 .

[225]  R. Webster Magnetic Resonance Spectroscopy , 1962, Nature.